HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | -7.37 Million USD | -449.68% |
| 2021 | 2.1 Million USD | 121.63% |
| 2020 | -9.75 Million USD | -368.34% |
| 2019 | 3.63 Million USD | 191.65% |
| 2018 | 1.24 Million USD | 202.64% |
| 2017 | -1.21 Million USD | -128.43% |
| 2016 | 4.27 Million USD | -43.46% |
| 2015 | 7.55 Million USD | -1.07% |
| 2014 | 7.63 Million USD | 531.16% |
| 2013 | -1.77 Million USD | 75.09% |
| 2012 | -7.11 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 984.3 Thousand USD | 113.34% |
| 2023 Q2 | - USD | -100.0% |
| 2022 Q1 | -5.14 Million USD | -343.88% |
| 2022 FY | -7.37 Million USD | -449.68% |
| 2022 Q2 | 3.31 Million USD | 164.35% |
| 2022 Q4 | -7.37 Million USD | -359.7% |
| 2022 Q3 | 2.84 Million USD | -14.21% |
| 2021 Q2 | -2.68 Million USD | 72.69% |
| 2021 Q1 | -9.83 Million USD | -0.84% |
| 2021 FY | 2.1 Million USD | 121.63% |
| 2021 Q3 | 1.71 Million USD | 163.99% |
| 2021 Q4 | 2.1 Million USD | 22.74% |
| 2020 Q4 | -9.75 Million USD | -54.4% |
| 2020 Q2 | -8.09 Million USD | -1190.55% |
| 2020 Q1 | 742.53 Thousand USD | -79.57% |
| 2020 FY | -9.75 Million USD | -368.34% |
| 2020 Q3 | -6.31 Million USD | 21.99% |
| 2019 Q1 | 3.66 Million USD | 193.88% |
| 2019 Q4 | 3.63 Million USD | 115.5% |
| 2019 Q2 | -395.24 Thousand USD | -110.79% |
| 2019 FY | 3.63 Million USD | 191.65% |
| 2019 Q3 | -23.44 Million USD | -5832.38% |
| 2018 Q1 | -10.98 Million USD | -804.36% |
| 2018 FY | 1.24 Million USD | 202.64% |
| 2018 Q3 | 3.47 Million USD | -9.07% |
| 2018 Q4 | 1.24 Million USD | -64.12% |
| 2018 Q2 | 3.82 Million USD | 134.79% |
| 2017 Q1 | 7.58 Million USD | 77.63% |
| 2017 FY | -1.21 Million USD | -128.43% |
| 2017 Q4 | -1.21 Million USD | 27.88% |
| 2017 Q3 | -1.68 Million USD | 62.7% |
| 2017 Q2 | -4.51 Million USD | -159.5% |
| 2016 Q1 | 10.85 Million USD | 43.67% |
| 2016 Q2 | 6.98 Million USD | -35.69% |
| 2016 Q3 | 7.63 Million USD | 9.36% |
| 2016 Q4 | 4.27 Million USD | -44.04% |
| 2016 FY | 4.27 Million USD | -43.46% |
| 2015 FY | 7.55 Million USD | -1.07% |
| 2015 Q1 | 12.38 Million USD | 62.19% |
| 2015 Q4 | 7.55 Million USD | -7.39% |
| 2015 Q3 | 8.15 Million USD | 1720.22% |
| 2015 Q2 | -503.52 Thousand USD | -104.07% |
| 2014 Q4 | 7.63 Million USD | 146.17% |
| 2014 Q1 | 1.81 Million USD | 202.49% |
| 2014 Q2 | 7.6 Million USD | 318.91% |
| 2014 Q3 | 3.1 Million USD | -59.21% |
| 2014 FY | 7.63 Million USD | 531.16% |
| 2013 Q4 | -1.77 Million USD | 0.0% |
| 2013 FY | -1.77 Million USD | 75.09% |
| 2012 FY | -7.11 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 434.402% |
| Arrayit Corporation | 1.05 Million USD | 798.849% |
| Atlantic International Corp. | 236.49 Thousand USD | 3219.253% |
| Biocept, Inc. | -788 Thousand USD | -836.156% |
| Bioqual, Inc. | -12 Million USD | 38.562% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 32541.66% |
| DermTech, Inc. | 17.65 Million USD | 141.788% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 98.711% |
| iMD Companies, Inc. | 1.11 Million USD | 761.064% |
| IDenta Corp. | 524.85 Thousand USD | 1505.522% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 195.879% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | -27270.544% |
| InVitro International | -313.14 Thousand USD | -2255.771% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 571.093% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -1034529.593% |
| Medical Imaging Corp. | 3.79 Million USD | 294.593% |
| NovelStem International Corp. | 3.52 Million USD | 309.48% |
| Optigenex Inc. | 8.93 Million USD | 182.571% |
| PharmChem, Inc. | -1.49 Million USD | -393.633% |
| Proteome Sciences plc | 14.57 Million USD | 150.619% |
| Response Genetics, Inc | -13.08 Million USD | 43.627% |
| Rennova Health, Inc. | 14.82 Million USD | 149.744% |
| RushNet, Inc. | 4.8 Million USD | 253.659% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 5540.64% |
| Stella Diagnostics Inc. | 6.19 Million USD | 219.116% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 513.411% |
| Todos Medical Ltd. | 38.31 Million USD | 119.254% |